Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SHANGHAI MIRACOGEN INC.”

5 pharma patents match "SHANGHAI MIRACOGEN INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "SHANGHAI MIRACOGEN INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “SHANGHAI MIRACOGEN INC.” · 30,257 patents in full index Clear search

  1. US 12290505

    Tissue factor-targeted antibody-drug conjugate

    SHANGHAI MIRACOGEN INC. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  2. US 12103978

    Methods and materials for treating cancer

    SHANGHAI MIRACOGEN INC. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  3. US 11534495

    Tissue factor-targeted antibody-drug conjugate

    SHANGHAI MIRACOGEN INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  4. US 10792370

    Antibody-drug conjugate

    SHANGHAI MIRACOGEN INC. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted
  5. US 10676537

    Antibody targeted to tissue factor, preparation method therefor, and use thereof

    SHANGHAI MIRACOGEN INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted